The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Addiction as a Coping Response: Hyperkatifeia, Deaths of Despair, and COVID-19
Abstract
Back to table of contents Previous article Next article Reviews and OverviewsFull AccessAddiction as a Coping Response: Hyperkatifeia, Deaths of Despair, and COVID-19George F. Koob, Ph.D., Patricia Powell, Ph.D., Aaron White, Ph.D.George F. Koob, Ph.D., Patricia Powell, Ph.D., Aaron White, Ph.D.Published Online:1 Nov 2020https://doi.org/10.1176/appi.ajp.2020.20091375AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail Neuroadaptations that occur in response to repeated substance use diminish the euphoria that is produced by the acute use of a drug and increase levels of physical and emotional stress between drug use episodes. An individual who struggles with addiction can be tempted to return to drug use to reduce misery that is caused by use of the drug itself. Recent developments, including an increase in "deaths of despair" in the United States, increases in alcohol use by some individuals as a result of the 2019 coronavirus disease (COVID-19) pandemic, and limited availability of in-person treatment and recovery support, raise concerns about the use of alcohol and other drugs in an effort to cope with distress. In this article, we examine the role of negative reinforcement in the development of addiction, discuss neuroadaptations that lead to increases in emotional and physical misery between episodes of drug use, and explore how using substances to cope with the emotional strain of social isolation and financial uncertainty during the COVID-19 pandemic could contribute to deaths of despair.Conceptual Framework of AddictionAlcohol Use Disorder as a Prototype AddictionAlcohol use disorder (AUD) can be defined as a chronically relapsing disorder that is associated with compulsive alcohol drinking, the loss of control over intake, and the emergence of a negative emotional state when alcohol is no longer available. Patterns of alcohol use in AUD can range from intermittent episodes of binge alcohol intake to prolonged heavy drinking over longer periods that progresses to continual drinking for fear of withdrawal. Comorbid affective disorders, a history of trauma, and exposure to stressors increase the likelihood of developing AUD (1, 2). Abstinence from such alcohol binges or chronic high alcohol intake is characterized by a withdrawal syndrome with severe emotional and somatic symptoms and intense craving for alcohol. Negative emotional states commonly trigger relapse (3, 4), and such negative emotional states can be driven by excessive alcohol consumption itself. Like other substance use disorders, AUD is now considered a spectrum disorder, as described in DSM-5 (5), which provides a framework for determining the intensity of the disorder based on the number of symptoms the individual presents.Heuristic Framework for AddictionA heuristic framework for studying addiction, characterized by a three-stage cycle—binge/intoxication, withdrawal/negative affect, and preoccupation/anticipation—provides a starting point for exploring our theme in this article, namely, the intersection between alcohol addiction, deaths of despair, and social isolation that are caused by the COVID-19 pandemic (6, 7). Under this framework, dysregulation occurs in three functional domains that reflect the three stages of the addiction cycle: incentive salience/pathological habits in the binge/intoxication stage, negative emotional states in the withdrawal/negative affect stage, and executive function deficits in the preoccupation/anticipation stage. These three domains and stages are hypothesized to be mediated by three major neurocircuitry elements: basal ganglia, extended amygdala, and prefrontal cortex, respectively (6). An individual can enter the addiction cycle at any of these three stages (6) (Figure 1).FIGURE 1. Conceptual framework for the neurobiological basis of substance use disordersaa The framework involves a three-stage cycle—binge/intoxication, withdrawal/negative affect, and preoccupation/anticipation. These three stages involve dysregulations in three functional domains (incentive salience/habits, negative emotional states, and executive function) that are mediated by three major neurocircuitry elements (basal ganglia, extended amygdala, and prefrontal cortex, respectively). The negative emotional state of drug withdrawal, termed hyperkatifeia, can be facilitated and exacerbated by non-drug-related allostatic loads, such as genetics, epigenetics, childhood trauma, and psychiatric comorbidity, in addition to excessive drinking. Hyperkatifeia in turn drives the negative reinforcement source of motivation for compulsive-like alcohol seeking and using. Hyperkatifeia can drive impulsivity via negative urgency that is associated with relapse in the preoccupation/anticipation stage and then a return to the binge/intoxication stage. Hyperkatifeia can also drive the malaise of protracted abstinence that sets up a return to the binge/intoxication stage via cravi
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As recently summarized by Koob et al. in an integrative psycho-biological model for addiction, individuals enter the “addiction cycle” through deficient reward-related neural circuits and/or aversive physiological and psychological symptoms which are intensified rather than diminished by prolonged substance intake.”
From Addiction Psychotherapy: Going Beyond Self-Medication (2022) · cites this paper as [8]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Phillips, R. A. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1982.tb05283.x · Cited by 3,934
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Self-citationRising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century
Case, A., & Deaton, A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518393112 · Cited by 2,759
Drug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535
Self-citationRelapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors
Washton, A. M. (1986) · Journal of Studies on Alcohol · doi:10.15288/jsa.1986.47.260 · Cited by 2,531
Addiction motivation reformulated: an affective processing model of negative reinforcement
Baker, T. B., Piper, M. E., McCarthy, D. E., Majeskie, M. R., & Fiore, M. C. (2004) · Psychological Review · doi:10.1037/0033-295x.111.1.33 · Cited by 2,162
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Self-citationInternational Statistical Classification of Diseases and Related Health Problems 10th Revision
(2013) · Oxford University Press eBooks · doi:10.1093/med/9780199669493.005.0005 · Cited by 2,069
Losing control: how and why people fail at self-regulation
(1995) · Choice Reviews Online · doi:10.5860/choice.32-6508 · Cited by 1,924
Research works printed but not linked: 3
- Baker TB, 1986, Nebr Symp Motiv, 34, 257
- Caputo F, J Psychopharmacol
- Warner M, 2016, Natl Vital Stat Rep, 65, 1
Cited by
Sorted by citations
The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis
Ciccarone, D. (2021) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000717 · Cited by 987
Alcohol-Related Deaths During the COVID-19 Pandemic
White, A. M., Castle, I. P., Powell, P. A., Hingson, R., & Koob, G. F. (2022) · JAMA · doi:10.1001/jama.2022.4308 · Cited by 370
Self-citationThe Incentive-Sensitization Theory of Addiction 30 Years On
Robinson, T. E., & Berridge, K. C. (2024) · Annual Review of Psychology · doi:10.1146/annurev-psych-011624-024031 · Cited by 146
“Koob and colleagues (Koob et al. 2020, Koob 2021) proposed that the chief b-process mechanism for distress feelings is mediated by the release of CRF in the extended amygdala (i.e., central nucleus of the amygdala plus bed nucleus of the stria terminalis) (Koob & Le Moal 1997, 2001; Volkow et al.…”
Alcohol Use Disorder Treatment: Problems and Solutions
Koob, G. F. (2024) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-031323-115847 · Cited by 126
Self-citationHien, D. A., Morgan-López, A. A., Saavedra, L. M., Ruglass, L. M., Ye, A., López-Castro, T., Fitzpatrick, S., Killeen, T. K., Norman, S. B., Ebrahimi, C. T., et al. (2023) · American Journal of Psychiatry · doi:10.1176/appi.ajp.22010071 · Cited by 99
From compulsivity to compulsion: the neural basis of compulsive disorders
Robbins, T. W., Banca, P., & Belin, D. (2024) · Nature reviews. Neuroscience · doi:10.1038/s41583-024-00807-z · Cited by 111
“…including both ‘I want’ (as in craving for drugs in the absence of withdrawal) and ‘I need’ (as in craving for drugs in withdrawal), depending on which of the positive ( incentive motivation ) or negative (anxiety or frustration) affective systems are predominantly recruited at the time 13,14 .”
Anhedonia, Hyperkatifeia, and Negative Reinforcement in Substance Use Disorders
Koob, G. F. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2021_288 · Cited by 92
Self-citationGonçalves, P. D., Moura, H. F., do Amaral, R. A., Castaldelli-Maia, J. M., & Malbergier, A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.581113 · Cited by 87
Xu, S., Park, M., Kang, U. G., Choi, J., & Koo, J. W. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.685964 · Cited by 64
Feingold, D., Neria, Y., & Bitan, D. T. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.04.022 · Cited by 59
Pathways to the persistence of drug use despite its adverse consequences
McNally, G. P., Jean-Richard-dit-Bressel, P., Millan, E. Z., & Lawrence, A. J. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02040-z · Cited by 58
“Here, individuals learn from experience that drug taking augments positive emotional states and/or ameliorates negative ones (boredom, social exclusion, depressed mood, drug withdrawal) [107 – 110].”
BackgroundAlcohol and the Etiology of Depression
Nunes, E. V. (2023) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230004 · Cited by 47
Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes
Matzopoulos, R., Morlock, R., Morlock, A., Lerer, B., & Lerer, L. B. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.780696 · Cited by 57
“This has manifested in the US through an increase in drinking and alcohol related harms (15), increased anxiety, depression, and social isolation among people with substance use disorders (16), and rising addiction rates (17).”
Quantifying excess deaths among solid organ transplant recipients in the COVID-19 era
Massie, A. B., Werbel, W. A., Avery, R. K., et al. (2022) · American Journal of Transplantation · doi:10.1111/ajt.17036 · Cited by 46
Koob, G. F., & Vendruscolo, L. F. (2023) · Current topics in behavioral neurosciences · doi:10.1007/7854_2023_424 · Cited by 46
Self-citationAlcohol Use Disorder and Chronic Pain: An Overlooked Epidemic
Aquino, J. P. D., Sloan, M. E., Nunes, J. C., Costa, G. P. A., Katz, J. L., de Oliveira, D., Ra, J., Tang, V. M., & Petrakis, I. L. (2024) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230886 · Cited by 44
COVID-19, Mental Health, and Chronic Illnesses: A Syndemic Perspective
Saqib, K., Qureshi, A. S., & Butt, Z. A. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20043262 · Cited by 46
“It is possible that rising pandemic-related stress and increased drug use may fuel an increase in mortality from overdoses, suicide, and alcohol-related liver disease since the pandemic started against the backdrop of rising deaths from despair in the United States [91].”
BackgroundVenkatesh, A. K., Janke, A. T., Kinsman, J. M., Rothenberg, C., Goyal, P., Malicki, C., D’Onofrio, G., Taylor, A., & Hawk, K. F. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262136 · Cited by 41
Wang, W., Xie, X., Zhuang, X., Huang, Y., Tan, T., Gangal, H., Huang, Z., Purvines, W., Wang, X., Stefanov, A., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112089 · Cited by 39
“84 Therefore, our results indicate a circuit that likely mediates hyperkatifeia following opioid withdrawal, which may drive relapse.”
Availability of Illegal Drugs During the COVID-19 Pandemic in Western Germany
Scherbaum, N., Bonnet, U., Hafermann, H., Schifano, F., Bender, S., Grigoleit, T., Kuhn, J., Nyhuis, P. W., Preuss, U. W., Reymann, G., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.648273 · Cited by 38
Substance Use Disorders and Addiction: Mechanisms, Trends, and Treatment Implications
Kalin, N. H. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20091382 · Cited by 32
Complex Persistent Opioid Dependence—an Opioid-induced Chronic Pain Syndrome
Manhapra, A. (2022) · Current Treatment Options in Oncology · doi:10.1007/s11864-022-00985-x · Cited by 31
Votaw, V. R., Stein, E., & Witkiewitz, K. A. (2021) · Alcohol and Alcoholism · doi:10.1093/alcalc/agab012 · Cited by 30
“Negative affect has been widely implicated in alcohol use disorder (AUD) etiology (McHugh and Goodman, 2019; Koob et al., 2020) and in predicting and mediating AUD treatment outcomes (Swan et al.”
BackgroundKoob, G. F., Kandel, D. B., Baler, R., & Volkow, N. D. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_29-1 · Cited by 31
Self-citationSeemiller, L. R., Flores-Cuadra, J. A., Griffith, K. R., Smith, G. C., & Crowley, N. A. (2024) · Neurobiology of Stress · doi:10.1016/j.ynstr.2024.100605 · Cited by 25
“For example, some may use alcohol as a stress coping mechanism (Koob et al., 2020).”
BackgroundInfluentialAllostasis theory in opioid tolerance
Ballantyne, J. C., & Koob, G. F. (2021) · Pain · doi:10.1097/j.pain.0000000000002280 · Cited by 25
Self-citationAlcohol-Endocannabinoid Interactions: Implications for Addiction-Related Behavioral Processes
Serrano, A. (2022) · Alcohol research · doi:10.35946/arcr.v42.1.09 · Cited by 25
“affective states and increased alcohol consumption that facilitates the development of alcohol use disorder (AUD).(4) Extensive efforts”
BackgroundVera, B. D. V., Carmona, J., Lozano, O. M., Parrado‐González, A., Giné, C. V., Pautassi, R. M., & Fernández‐Calderón, F. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194468 · Cited by 28
Addiction Psychotherapy: Going Beyond Self-Medication
Feingold, D., & Tzur Bitan, D. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.820660 · Cited by 23
Mitochondrial and metabolic features of salugenesis and the healing cycle
Naviaux, R. K. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.04.003 · Cited by 27
The Great Divide: Education, Despair and Death
Case, A. C., & Deaton, A. (2021) · Annual Review of Economics · doi:10.1146/annurev-economics-051520-015607 · Cited by 41
The cultural equivalence of measurement in substance use research.
Lopez-Vergara, H. I., Yang, M., Weiss, N. H., Stamates, A. L., Spillane, N. S., & Ewing, S. W. F. (2021) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000512 · Cited by 22
King, A. C., Vena, A. A., Howe, M. M., Feather, A. R., & Cao, D. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01340-2 · Cited by 21
“Considering this body of work within the theoretical framework of the allostasis model of addiction [45], the observation of pronounced euphoric and hedonic effects of alcohol supports a possible persistence of the purported binge-intoxication stage that occurs prior to, or in tandem with the subsequent negative affec…”
BackgroundWilkerson, J. L., Alberti, L. B., Thakur, G. A., Makriyannis, A., & Milligan, E. D. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147721 · Cited by 20
Luk, J. W., Satre, D. D., Cheung, R. C., Wong, R. J., Monto, A., Chen, J. Y., Batki, S. L., Ostacher, M. J., Snyder, H. R., Shui, A. M., et al. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000379 · Cited by 19
“[ 6,7 ] According to a meta-analysis, 16% of the individuals in the United States decreased alcohol consumption during the pandemic, whereas 29% increased alcohol consumption.”
MethodRehm, J. T., Assanangkornchai, S., Hendershot, C. S., Franklin, A., Neufeld, M., Hassan, A. S., & Shield, K. D. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01496-5 · Cited by 25
Martí‐Prats, L., Giuliano, C., Domi, A., Puaud, M., Peña‐Oliver, Y., Fouyssac, M., McKenzie, C., Everitt, B. J., & Belin, D. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02256-z · Cited by 19
“Across species the individual tendency to rely on the anxiolytic effects of alcohol to cope with stress [42, 50, 51], including that induced by the SIP procedure [52], has been associated with an increased vulnerability to switch from controlled to compulsive alcohol use, a key feature of alcohol…”
BackgroundInfluentialIncidence of Hospitalizations Involving Alcohol Withdrawal Syndrome in a Primary Care Population
Steel, T. L., Matson, T. E., Hallgren, K. A., Oliver, M. M., Jack, H. E., Berger, D. B., & Bradley, K. A. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.38128 · Cited by 17
Linn, B. K., Zhao, J., Stasiewicz, P. R., LaBarre, C., Wilding, G. E., & Bradizza, C. M. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109695 · Cited by 17
Evens, R., Reiche, S., Marek, R. M., Moon, D. U., Groß, R. E., Romanello, A., Masah, D. J., Scicchitano, M., Gutwinski, S., Montag, C., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.732028 · Cited by 15
A conceptual framework for the intersection of hyperalgesia and hyperkatifeia in alcohol addiction
Koob, G. F., & Vendruscolo, L. F. (2025) · Alcohol · doi:10.1016/j.alcohol.2025.08.004 · Cited by 14
Self-citationChanges in Alcohol-Related Behaviors and Quality of Life During the COVID-19 Pandemic
Luk, J. W., Stangl, B. L., Gunawan, T., et al. (2022) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.22br14462 · Cited by 13
“After excluding participants that (1) did not respond (n = 548); (2) declined/withdrew (n = 233); (3) completed the survey after March 11, 2021 (n = 23); and (4) had missing data on primary study variables (n = 21), 378 participants were enrolled in the NIAAA COVID-19 Pandemic Impact of Alcohol (C19-PIA) Study.”
BackgroundFlores‐Ramirez, F. J., Illenberger, J. M., Pascasio, G., Terenius, L. Y., & Martin‐Fardon, R. (2024) · Scientific Reports · doi:10.1038/s41598-024-56500-9 · Cited by 13
Pancreatic Pain—Knowledge Gaps and Research Opportunities in Children and Adults
Uç, A., Andersen, D. K., Apkarian, A. V., Bellin, M. D., Colloca, L., Drewes, A. M., Dunbar, E. K., Forsmark, C. E., Goodman, M. T., Kapural, L., et al. (2021) · Pancreas · doi:10.1097/mpa.0000000000001899 · Cited by 12
Self-citationPich, E. M., Tarnanas, I., Brigidi, P., & Collo, G. (2025) · Neurobiology of Stress · doi:10.1016/j.ynstr.2025.100713 · Cited by 16
“Several of these deficits of mild-to-moderate intensities were described at the second-third stage of the AUD Addiction Cycle (Kwako et al., 2016; Koob et al., 2020, NIAAA Core Resource on Alcohol, 2024).”
Folgen der COVID-19-Pandemie für Menschen mit Schizophrenie, Demenz und Abhängigkeitserkrankungen
Adorjan, K., Haußmann, R., Rauen, K., & Pogarell, O. M. (2021) · Der Nervenarzt · doi:10.1007/s00115-021-01105-0 · Cited by 12
Noradrenergic Mechanisms and Circuitry of Hyperkatifeia in Alcohol Use Disorder
Varodayan, F. P., Erikson, C. M., Scroger, M. V., & Roberto, M. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.09.009 · Cited by 12
“It has been hypothesized that negative emotionality can act as a preexisting condition to promote excessive drinking and precipitate direct entry into any stage of the AUD cycle (Figure 1) (3).”
BackgroundInfluentialAffective scaffolding in addiction
Lavallee, Z. (2023) · Inquiry · doi:10.1080/0020174x.2023.2194321 · Cited by 11
Chronic ethanol exposure produces sex-dependent impairments in value computations in the striatum
Cheng, Y., Magnard, R., Langdon, A., Lee, D., & Janak, P. H. (2025) · Science Advances · doi:10.1126/sciadv.adt0200 · Cited by 16
“The intolerance of uncertainty has also been associated with risky EtOH use behavior (54) and “hyperkatifeia” (55).”
COVID-19 and Stress-Related Disorders
Kalin, N. H. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2021.21040371 · Cited by 11
The Effects of Mindfulness-Based Intervention on Emotion-Related Impulsivity in Addictive Disorders
Parisi, A. B., Hudak, J., & Garland, E. L. (2023) · Current Addiction Reports · doi:10.1007/s40429-023-00501-7 · Cited by 13
McCabe, E. M., Luk, J. W., Stangl, B. L., Schwandt, M. L., Ziausyte, U., Kim, H. H., Vergeer, R. R., Gunawan, T., Fede, S. J., Momenan, R., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0297060 · Cited by 10
“Individuals may turn to positive or negative health behaviors to cope during the pandemic [7, 21, 24].”
He, Q., & Zeng, Z. (2024) · Communication and the Public · doi:10.1177/20570473241239359 · Cited by 14
“First, addictive behaviors, which are central to our investigation, are widely recognized as responses to environmental stimuli (Koob et al., 2020).”
A probabilistic model of relapse in drug addiction
Mao, S., Chou, T., & D'Orsogna, M. R. (2024) · Mathematical Biosciences · doi:10.1016/j.mbs.2024.109184 · Cited by 16
“Similarly, since drug abuse is known to exacerbate negative emotional distress [25, 47, 48, 64], we can assume that κ b ( t ) is a monotonically increasing function with κ b ( t = 0) = κ b , 0 that increases towards κ b ( t → ∞ ) = κ ∗ b > κ b , 0 . minds In this case, negative a ff ects linger less…”
BackgroundZhang, Y., Ma, Y., Fan, Y., Gao, Y., He, Y., Wang, Y., Nan, B., Liu, J., Liu, J., & Wang, Y. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.105424 · Cited by 10
Lommer, K., Schurr, T., Frajo-Apor, B., Plattner, B., Chernova, A., Conca, A., Fronthaler, M., Häring, C., Holzner, B., Macina, C., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.918465 · Cited by 11
Gerbaldo, T. B., & Antunes, J. L. F. (2022) · Saúde e Sociedade · doi:10.1590/s0104-12902022210649pt · Cited by 10
Behavioral therapies targeting reward mechanisms in substance use disorders
Wardle, M. C., Webber, H. E., Yoon, J. H., Heads, A. M. B., Stotts, A. L., Lane, S. D., & Schmitz, J. M. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173787 · Cited by 10
Ashwal-Malka, A., Tal-Kishner, K., & Feingold, D. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2021.107114 · Cited by 14
Quelch, D. R., Lingford-Hughes, A. R., John, B., Nutt, D., Bradberry, S., & Roderique‐Davies, G. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241294005 · Cited by 11
“…relapse and continued consumption, for example availability (Bowen et al., 2022; Durazzo and Meyerhoff, 2017; Stillman and Sutcliff, 2020), consumption may also be driven by a need to avoid, and fear of, AWS (Koob et al., 2020), rather than the desire to feel pleasure associated with consumption.”
Maternal risk factors for fetal alcohol spectrum disorders: Distal variables
May, P. A., Hasken, J. M., de Vries, M. M., Marais, A., Abdul-Rahman, O. A., Robinson, L. K., Adam, M. P., Manning, M. A., Kalberg, W. O., Buckley, D. G., et al. (2023) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15246 · Cited by 9
Hall, O. T., Vilensky, M. R., Teater, J. E., Bryan, C. J., Rood, K. M., Niedermier, J. A., Entrup, P., Gorka, S. M., King, A., Williams, D. A., et al. (2024) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2023.2298257 · Cited by 8
“Indeed, hyperkatifeia and pain are linked in the brain (10,13–17).”
There’s a Pill for That: Bad Pharmaceutical Scaffolding and Psychiatrization
Lavallee, Z. (2024) · Topoi · doi:10.1007/s11245-024-10147-3 · Cited by 9
“…that one reason many people use psychoactive drugs is to actively transform, alter, or regulate emotions and moods (e.g., Berking et al. 2011; Chester et al. 2016; Cooper et al. 1995; Garland et al. 2020; Hogarth 2020; Kober 2014; Koob et al. 2020; May et al. 2020; Verdejo-García et al. 2007).”
Parisi, A. B., Hudak, J., Froeliger, B., & Garland, E. L. (2023) · Nature Mental Health · doi:10.1038/s44220-023-00084-2 · Cited by 9
Luk, J. W., Geda, D. W., Stangl, B. L., Cheng, C., Schwandt, M. L., Goldman, D. A., Diazgranados, N., & Ramchandani, V. A. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1268890 · Cited by 10
Giorgi, S., Yaden, D. B., Eichstaedt, J. C., Ungar, L., Schwartz, H. A., Kwarteng, A. E., & Curtis, B. L. (2023) · Scientific Reports · doi:10.1038/s41598-023-34468-2 · Cited by 8
Critical care for patients with substance use disorders
Steel, T. L., Bhatraju, E. P., & Hills-Dunlap, K. (2023) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001080 · Cited by 8
“Critical care providers and researchers must take action in response towhat has been called the public health crisis of our time [79] – no longer the COVID19 pandemic, but ‘deaths of despair’ resulting from substance use to cope with social isolation and other sources of distress [57,80,81].”
BackgroundThe COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in Poland
Silczuk, A., Gujska, J. H., Wojtyniak, B., Camlet, K., Stępień, M., Stokwiszewski, J., & Juszczyk, G. (2023) · Medical Science Monitor · doi:10.12659/msm.940904 · Cited by 6
“Possible contributing factors involve increased alcohol consumption as a means of coping with pandemic-related problems and impeded access to health care [41].”
BackgroundMelkumyan, M., Annaswamy, V. M., Evans, A. M., Showemimo, O., McCullers, Z., Sun, D., Murphy, T. E., Vrana, K. E., Arnold, A. C., Raup‐Konsavage, W. M., et al. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1375440 · Cited by 7
“Further, external stressors, particularly during withdrawal, may lead individuals suffering from AUD to relapse to alleviate stress (Koob et al., 2020).”
BackgroundWhat makes for successful deployment of fear during a crisis?
Johnson, M., Flinders, M. V., & Degerman, D. (2021) · Global Discourse · doi:10.1332/204378921x16201509216560 · Cited by 7
Metaphoric Perceptions of Covid-19 Patients Related to the Disease
Çakmak, B., Çalık, A., & İnkaya, B. V. (2021) · Clinical Nursing Research · doi:10.1177/10547738211048312 · Cited by 7
“Depending on these situations, unfortunately, “deaths of despair” increase in patients, and lead to increasing the use of alcohol and other drugs to cope with the COVID-19 pandemic (Koob et al., 2020).”
BackgroundType D Personality, Stress Level, Life Satisfaction, and Alcohol Dependence in Older Men
Bejda, G., Kułak-Bejda, A., Waszkiewicz, N., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.712508 · Cited by 7
“Moreover, hyperkatifeia can drive impulsivity like relapse in the preoccupation or anticipation stage and then a return to the binge or intoxication stage (30).”
BackgroundAng, B. H., Gollapalli, S. D., Du, M., & Ng, S.-K. (2025) · Journal of Medical Internet Research · doi:10.2196/59524 · Cited by 6
Negative affectivity drivers of impulsivity in opioid use disorder
Vassileva, J., Psederska, E., & Bjork, J. M. (2025) · Nature Reviews Psychology · doi:10.1038/s44159-025-00404-6 · Cited by 6
“In addition, impairments in ‘hot’ state impulsivity involving impulsive choice might further decrease executive control and the capacity to resist urges for opioid use in the preoccupation/anticipation stage 168,232 .”
Manhapra, A., Stefanovics, E. A., Rhee, T. G., & Rosenheck, R. A. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109339 · Cited by 6
Graupensperger, S. A., Calhoun, B. H., Fleming, C. B., & Lee, C. M. (2023) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.22-00262 · Cited by 6
Chakraborty, S., & Sadachar, A. (2023) · Sustainability · doi:10.3390/su15097356 · Cited by 4
Syed, S. A., Sinha, R., Milivojevic, V., MacDougall, A., LaVallee, H., Angarita, G. A., & Fox, H. C. (2023) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2867 · Cited by 6
“Chronic alcohol use is linked to chronic alterations in the hypothalamic‐pituitary‐adrenal (HPA) axis and the sympathetic adrenal medullary system (Koob & Kreek, 2007), which are associated with relapse (Koob et al., 2020; Sliedrecht, de Waart, Witkiewitz, & Roozen, 2019).”
BackgroundMartenies, S. E., Wilson, A., Hoskovec, L., Bol, K. A., Burket, T. L., Podewils, L. J., & Magzamen, S. L. (2023) · Environmental Research · doi:10.1016/j.envres.2023.115591 · Cited by 6
Wu, J., Zhang, N., Ye, Q. L., et al. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1607248 · Cited by 5
Sleep disturbance and problematic alcohol use: Examination of sex and race differences
Dzierzewski, J. M., Ravyts, S. G., Martin, C. E., Polak, K., Nielson, S. A., Pomm, D., Dillon, P. M., Moore, T. B., Thacker, L. R., & Svikis, D. S. (2022) · Frontiers in Sleep · doi:10.3389/frsle.2022.1014610 · Cited by 5
“For individuals at risk, these crossing neurobiological pathways can lead to a vicious cycle where substance use and sleep disturbance continue to perpetuate one another (Koob et al., 2020).”
BackgroundHall, O. T., Gunawan, T., Teater, J. E., Bryan, C. J., Gorka, S. M., & Ramchandani, V. A. (2024) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2024.2350057 · Cited by 5
“Hyperkatifeia is considered to be the emotional corollary of hyperalgesia (7,24–26).”
Geda, D. W., Stangl, B. L., Arsenault, A., Thompson, M. F., Schwandt, M. L., Goldman, D. A., Ramchandani, V. A., Diazgranados, N., & Luk, J. W. (2024) · Alcohol and Alcoholism · doi:10.1093/alcalc/agae068 · Cited by 5
McCabe, E., DeSordi, S., Piepmeier, A. T., & Hall, E. E. (2023) · American Journal of Undergraduate Research · doi:10.33697/ajur.2023.083 · Cited by 5
Grigoropoulos, I. N., & Daoultzis, K. C. (2022) · Trends in Psychology · doi:10.1007/s43076-022-00159-6 · Cited by 5
“Research findings already underline alcohol misuse during the COVID-19 outbreak (Koob et al., 2020; Rehm et al., 2020).”
BackgroundResultSubstance Use and Concurrent Disorders: Current Context and the Need for Treatment Integration
Hendershot, C. S., & Foll, B. L. (2024) · The Canadian Journal of Psychiatry · doi:10.1177/07067437241305174 · Cited by 5
Parisi, A., Zgierska, A. E., Burzinski, C. A., Lennon, R. P., Jamison, R. N., Nakamura, Y., Barrett, B., Edwards, R. R., & Garland, E. L. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.109890 · Cited by 4
Blandino, K. L., DiLeo, A., Antonoudiou, P., Weiss, G. L., & Maguire, J. L. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06928-2 · Cited by 4
“Withdrawal/negative affect is associated with severe emotional symptoms, characterized by negative emotional states, termed hyperkatifeia, which commonly triggers relapse (Koob et al. 2020).”
Rausch, J., Entrup, P., Deaner, M., et al. (2024) · Canadian Journal of Pain · doi:10.1080/24740527.2024.2332198 · Cited by 4
Vergeer, R. R., Luk, J. W., Stangl, B. L., McCabe, E. M., Ziausyte, U., Schwandt, M. L., Goldman, D. A., Ramchandani, V. A., & Diazgranados, N. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1487277 · Cited by 5
“Speci fi cally, this association may be strengthened by high perceived stress, as stress is linked to maladaptive coping and problematic alcohol use, especially in the context of the pandemic (12 – 15).”
Training in Substance use Disorders, Part 1: Overview of Clinical Practice Recommendations
Bahji, A., Crockford, D. N., Brasch, J. S., Schütz, C. G., Buckley, L., Danilewitz, M., Dubreucq, S., Mak, M. S. B., & George, T. P. (2024) · The Canadian Journal of Psychiatry · doi:10.1177/07067437241231128 · Cited by 4
“In a Controlled Environment: This additional speci fi er is used if the individual is in an environment where access to the substance is restricted. emotional dysregulation, 74 – 76 all of which should be explored during the assessment.”
BackgroundMartí‐Prats, L., & Belin, D. (2024) · Brain Communications · doi:10.1093/braincomms/fcae169 · Cited by 4
Yu, R. A., Goulter, N., Godwin, J. W., & McMahon, R. J. (2023) · Clinical Child and Family Psychology Review · doi:10.1007/s10567-023-00459-y · Cited by 4
“…misuse, alcohol misuse, or suicide next to COVID-19 as separate yet co-occurring epidemics, calling for public policy to close the unexplained gap that exists between the way in which physical and mental illnesses are addressed (Koob et al., 2020; Linas et al, 2021; Porras-Segovia et al., 2021).”
BackgroundGiuliano, C., Martí‐Prats, L., Domi, A., Puaud, M., Peña‐Oliver, Y., McKenzie, C., Everitt, B. J., & Belin, D. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.27.509680 · Cited by 4
Zhang, X., Linn, B. K., & Moss, J. L. (2025) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2025.108115 · Cited by 3
Neurobiology of negative reinforcement as a driving force in alcohol addiction
Vendruscolo, L. F., & Koob, G. F. (2026) · Neuron · doi:10.1016/j.neuron.2026.04.038 · Cited by 4
Self-citationPetrović, Z. K., Peraica, T., Blažev, M., & Kozarić‐Kovačić, D. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1295977 · Cited by 3
“Pandemic-related stress may trigger alcohol drinking and substance use to ease coping with mental health challenges (3) and provide some relief from the pressure of prolonged stress (4).”
BackgroundChapter 55. Treatment of Alcohol Use Disorder
Mason, B. J., Ritvo, E. C., & Bonci, A. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as55 · Cited by 3
Szelest, I., Harries, B., Motluk, L., et al. (2021) · Healthcare Management Forum · doi:10.1177/08404704211027183 · Cited by 3
Vulnerability to substance abuse: A consideration of allostatic loading factors
O’Dell, L. E., Koob, G. F., & Nazarian, A. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108767 · Cited by 3
Self-citation
Metadata
- Authors
- Koob, G. F., Powell, P., & White, A.
- Affiliations
- National Institute on Drug Abuse (US)
- Venue
- American Journal of Psychiatry
- Published
- 2020-11-01
- Volume
- 177
- Issue
- 11
- Pages
- 1031-1037
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W3097574686
- Semantic Scholar
- b5a9b9e9c949110c13c1963babf3b07fc0c65f02
- Cited by
- 166
- References
- 59
- Citations by year
- 2026: 20 · 2025: 18 · 2024: 38 · 2023: 34 · 2022: 25 · 2021: 29 · 2020: 2
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
- Keywords
- addiction, deaths of despair, COVID-19 pandemic, alcoholism, negative reinforcement, neural adaptation, substance use as coping, social isolation, financial uncertainty, relapse, withdrawal, craving, alcohol withdrawal, substance use disorder treatment access, binge drinking, mood disorders, trauma exposure, stressors
- MeSH terms
- COVID-19, Adaptation, Psychological, Alcohol Drinking, Alcoholism, Emotions, Humans, Mortality, Pneumonia, Viral, United States, Behavior, Addictive, Coronavirus Infections, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review